3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Thoracic
1
Lymphoid
1
Conditions
Neoplasms
2
Frailty
2
Breast Neoplasms
2
Urogenital Neoplasms
1
Solid Neoplasm
1
Sarcopenia
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Hepatic Malignancies
1
Hematologic Neoplasms
1
Health Education
1
Communication
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Fulvestrant
63
Letrozole
53
Paclitaxel
49
Trastuzumab
41
pembrolizumab
40
ribociclib
37
Specimen Handling
37
palbociclib
36
Capecitabine
34
Carboplatin
33
Anastrozole
33
Tamoxifen
32
exemestane
29
pertuzumab
28
abemaciclib
28
Magnetic Resonance Spectroscopy
26
Cyclophosphamide
26
trastuzumab deruxtecan
24
Surveys and Questionnaires
21
Radiotherapy
18
Biopsy
18
olaparib
17
Standard of Care
16
Docetaxel
16
Blood Specimen Collection
16
Taxes
14
Mastectomy, Segmental
14
eribulin
13
elacestrant
13
130-nm albumin-bound paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Geriatric Assessment
×
90 days
×
Clear all
NCT05509751
2026-04-28
SOAR
University of Toronto
Phase NA
Active not recruiting
60 enrolled
NCT07531836
2026-04-15
PREHAB-BC65
Fundacion Miguel Servet
Phase NA
Recruiting
90 enrolled